Tag: Migraine
Functional Nasal Surgery Can Improve Headache Symptoms
Eighty-five percent of patients report partial or complete resolution of headaches postoperatively
Migraine With Aura Linked to Increase in Incident A-Fib
Risk for AF up for migraine with aura vs. no headache, migraine without visual aura, after adjustment
Risk of Cochlear Disorders Up With History of Migraine
Significantly increased risk of tinnitus in migraine cohort versus matched non-migraine cohort
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
FDA Approves Aimovig to Prevent Migraines
Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo
Fremanezumab Linked to Fewer Monthly Migraine Days
For episodic migraine patients, reduction in number of migraine days with monthly dosing, single dose
AAN: Erenumab Shows Promise for Hard-to-Treat Migraine
Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days
Noninvasive Brain Stimulation May Help Prevent Migraines
Single-pulse transcranial magnetic stimulation device is safe and easy to use
Low Risk of Serotonin Syndrome for Triptans + SSRI/SNRI
Researchers question FDA advisory warning on risk of concomitant use
